Cargando…

TGF-β1 Pretreatment Improves the Function of Mesenchymal Stem Cells in the Wound Bed

The wound healing process initiates after injury to a tissue and involves a series of orchestrated events to minimize the invasion of foreign matters such as bacteria and efficiently regenerate the damaged tissue. A variety of cells must be recruited to the tissue during wound healing. However, this...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghosh, Deepraj, McGrail, Daniel J., Dawson, Michelle R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378794/
https://www.ncbi.nlm.nih.gov/pubmed/28421182
http://dx.doi.org/10.3389/fcell.2017.00028
_version_ 1782519480863162368
author Ghosh, Deepraj
McGrail, Daniel J.
Dawson, Michelle R.
author_facet Ghosh, Deepraj
McGrail, Daniel J.
Dawson, Michelle R.
author_sort Ghosh, Deepraj
collection PubMed
description The wound healing process initiates after injury to a tissue and involves a series of orchestrated events to minimize the invasion of foreign matters such as bacteria and efficiently regenerate the damaged tissue. A variety of cells must be recruited to the tissue during wound healing. However, this process is severely disrupted in patients suffering from chronic illness, including diabetes, leading to impaired healing or non-healing wounds. Current avenues of treatment include negative-pressure therapy, wound debridement, growth factor replacement, and cell-based therapies. Among these therapies, mesenchymal stem cells (MSCs) delivery to the wound holds a very high promise due to the innate abilities of MSCs that include immunogenicity, plasticity, and self-renewal. Bone marrow derived MSCs have been shown to promote more rapid wound healing by increased cytokine production in diabetic mice. However, the lack of understanding of the mechanical and chemical interaction of the transplanted MSCs with the factors present in the regenerative niches limits their efficacy in the wound bed. In this study, we sought to understand how the changes in MSC biochemical and biophysical properties can affect their function in vitro and in vivo. We demonstrate that pretreatment of MSCs with the mechano-stimulatory soluble factor transforming growth factor (TGF-β1), which is highly expressed in injury sites, improves wound closure in a syngeneic murine wound model. This improved wound closure correlated with increased invasion into the wound bed. In vitro studies demonstrated that TGF-β1 pretreatment expedited wound closure by increasing adhesion, traction force, and migration even after removal of the stimulus. Furthermore, this response was mediated by the cytoskeletal protein focal adhesion kinase. Taken together, this study suggests that defined chemical stimuli can benefit site specific adaptability of MSCs to improve their function and therapeutic usefulness.
format Online
Article
Text
id pubmed-5378794
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-53787942017-04-18 TGF-β1 Pretreatment Improves the Function of Mesenchymal Stem Cells in the Wound Bed Ghosh, Deepraj McGrail, Daniel J. Dawson, Michelle R. Front Cell Dev Biol Cell and Developmental Biology The wound healing process initiates after injury to a tissue and involves a series of orchestrated events to minimize the invasion of foreign matters such as bacteria and efficiently regenerate the damaged tissue. A variety of cells must be recruited to the tissue during wound healing. However, this process is severely disrupted in patients suffering from chronic illness, including diabetes, leading to impaired healing or non-healing wounds. Current avenues of treatment include negative-pressure therapy, wound debridement, growth factor replacement, and cell-based therapies. Among these therapies, mesenchymal stem cells (MSCs) delivery to the wound holds a very high promise due to the innate abilities of MSCs that include immunogenicity, plasticity, and self-renewal. Bone marrow derived MSCs have been shown to promote more rapid wound healing by increased cytokine production in diabetic mice. However, the lack of understanding of the mechanical and chemical interaction of the transplanted MSCs with the factors present in the regenerative niches limits their efficacy in the wound bed. In this study, we sought to understand how the changes in MSC biochemical and biophysical properties can affect their function in vitro and in vivo. We demonstrate that pretreatment of MSCs with the mechano-stimulatory soluble factor transforming growth factor (TGF-β1), which is highly expressed in injury sites, improves wound closure in a syngeneic murine wound model. This improved wound closure correlated with increased invasion into the wound bed. In vitro studies demonstrated that TGF-β1 pretreatment expedited wound closure by increasing adhesion, traction force, and migration even after removal of the stimulus. Furthermore, this response was mediated by the cytoskeletal protein focal adhesion kinase. Taken together, this study suggests that defined chemical stimuli can benefit site specific adaptability of MSCs to improve their function and therapeutic usefulness. Frontiers Media S.A. 2017-04-04 /pmc/articles/PMC5378794/ /pubmed/28421182 http://dx.doi.org/10.3389/fcell.2017.00028 Text en Copyright © 2017 Ghosh, McGrail and Dawson. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cell and Developmental Biology
Ghosh, Deepraj
McGrail, Daniel J.
Dawson, Michelle R.
TGF-β1 Pretreatment Improves the Function of Mesenchymal Stem Cells in the Wound Bed
title TGF-β1 Pretreatment Improves the Function of Mesenchymal Stem Cells in the Wound Bed
title_full TGF-β1 Pretreatment Improves the Function of Mesenchymal Stem Cells in the Wound Bed
title_fullStr TGF-β1 Pretreatment Improves the Function of Mesenchymal Stem Cells in the Wound Bed
title_full_unstemmed TGF-β1 Pretreatment Improves the Function of Mesenchymal Stem Cells in the Wound Bed
title_short TGF-β1 Pretreatment Improves the Function of Mesenchymal Stem Cells in the Wound Bed
title_sort tgf-β1 pretreatment improves the function of mesenchymal stem cells in the wound bed
topic Cell and Developmental Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378794/
https://www.ncbi.nlm.nih.gov/pubmed/28421182
http://dx.doi.org/10.3389/fcell.2017.00028
work_keys_str_mv AT ghoshdeepraj tgfb1pretreatmentimprovesthefunctionofmesenchymalstemcellsinthewoundbed
AT mcgraildanielj tgfb1pretreatmentimprovesthefunctionofmesenchymalstemcellsinthewoundbed
AT dawsonmicheller tgfb1pretreatmentimprovesthefunctionofmesenchymalstemcellsinthewoundbed